Antioxidants (Jan 2022)

The Crosstalk between GPR81/IGFBP6 Promotes Breast Cancer Progression by Modulating Lactate Metabolism and Oxidative Stress

  • Lucia Longhitano,
  • Stefano Forte,
  • Laura Orlando,
  • Stephanie Grasso,
  • Alessandro Barbato,
  • Nunzio Vicario,
  • Rosalba Parenti,
  • Paolo Fontana,
  • Angela M. Amorini,
  • Giuseppe Lazzarino,
  • Giovanni Li Volti,
  • Michelino Di Rosa,
  • Arcangelo Liso,
  • Barbara Tavazzi,
  • Giacomo Lazzarino,
  • Daniele Tibullo

DOI
https://doi.org/10.3390/antiox11020275
Journal volume & issue
Vol. 11, no. 2
p. 275

Abstract

Read online

Breast cancer is the most frequent tumor and the leading cause of cancer deaths in women. In recent years, lactate metabolism and, in particular, its receptor GPR81 have been shown to play a vital role in cancer biology. GPR81 is upregulated in breast cancer and promotes tumor growth by tumor cell-derived lactate. Therefore, the search for possible crosstalk and the involvement of new molecules capable of generating this pathology is always in continuous development. In this study, the relationship between GPR81 and IGFBP6 protein in tumor growth and oxidative stress in the human breast cancer cell line MDA-MB-231 was studied. Cells were treated with lactate or the GPR81 receptor agonist and antagonist 3,5-DHBA and 3-OBA, respectively. In addition, oxidative stress and proliferation were also evaluated in cells challenged with the recombinant IGFBP6 protein. Our data showed that lactate induced cell proliferation and wound healing of the MDA-231 breast cancer cell through the overexpression of both the lactate receptor GPR81 and IGFBP6. The increase in IGFBP6 was able, in turn, to improve the mitochondrial fitness and redox state, as suggested by the reduced levels of mitochondrial ROS production after IGFBP6 treatment, presumably mediated by the increase in the ROS detoxifying genes HMOX1, GSTK1 and NQO1. In conclusion, our data highlight a novel axis between GPR81 and IGFBP6 in MDA-231 cells able to modulate lactate metabolism and oxidative stress. This complex signaling may represent a new therapeutic target for breast cancer.

Keywords